374 related articles for article (PubMed ID: 21838832)
1. Extracellular matrix molecules implicated in hypertrophic and keloid scarring.
Sidgwick GP; Bayat A
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):141-52. PubMed ID: 21838832
[TBL] [Abstract][Full Text] [Related]
2. Keloids and hypertrophic scars: are they two different sides of the same coin?
Köse O; Waseem A
Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
4. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
Slemp AE; Kirschner RE
Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
[TBL] [Abstract][Full Text] [Related]
5. The role of nitric oxide in the formation of keloid and hypertrophic lesions.
Cobbold CA
Med Hypotheses; 2001 Oct; 57(4):497-502. PubMed ID: 11601878
[TBL] [Abstract][Full Text] [Related]
6. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
7. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
8. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
9. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
10. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation.
Dasu MR; Hawkins HK; Barrow RE; Xue H; Herndon DN
J Pathol; 2004 Apr; 202(4):476-85. PubMed ID: 15095275
[TBL] [Abstract][Full Text] [Related]
12. Immune cells and associated molecular markers in dermal fibrosis with focus on raised cutaneous scars.
Kidzeru EB; Lebeko M; Sharma JR; Nkengazong L; Adeola HA; Ndlovu H; P Khumalo N; Bayat A
Exp Dermatol; 2023 May; 32(5):570-587. PubMed ID: 36562321
[TBL] [Abstract][Full Text] [Related]
13. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
Berman B; Maderal A; Raphael B
Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
15. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.
Torkian BA; Yeh AT; Engel R; Sun CH; Tromberg BJ; Wong BJ
Arch Facial Plast Surg; 2004; 6(3):180-7. PubMed ID: 15148128
[TBL] [Abstract][Full Text] [Related]
16. Signaling networks in barrier homeostasis. The mystery widens.
Elias PM; Ansel JC; Woods LD; Feingold KR
Arch Dermatol; 1996 Dec; 132(12):1505-6. PubMed ID: 8961883
[No Abstract] [Full Text] [Related]
17. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation.
Kim SH; Jung SH; Chung H; Jo DI; Kim CK; Park SH; Won KJ; Jeon HS; Kim B
Arch Dermatol Res; 2014 May; 306(4):347-57. PubMed ID: 24402284
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.
Rossiello L; D'Andrea F; Grella R; Signoriello G; Abbondanza C; De Rosa C; Prudente M; Morlando M; Rossiello R
Wound Repair Regen; 2009; 17(5):750-7. PubMed ID: 19769727
[TBL] [Abstract][Full Text] [Related]
20. Control of wound contraction. Basic and clinical features.
Nedelec B; Ghahary A; Scott PG; Tredget EE
Hand Clin; 2000 May; 16(2):289-302. PubMed ID: 10791174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
